Related references
Note: Only part of the references are listed.No association between bone mass and prolactin levels among patients with schizophrenia
Norio Sugawara et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Bone Mineral Density and Osteoporosis Risk in Older Patients With Schizophrenia
Do-Un Jung et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Bone mass in schizophrenia and normal populations across different decades of life
Jenn-Huei Renn et al.
BMC MUSCULOSKELETAL DISORDERS (2009)
Ultrasound bone mass in schizophrenic patients on antipsychotic therapy
Purificacin Rey-Sanchez et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Body composition in psychotic disorders: a general population survey
S. E. Saarni et al.
PSYCHOLOGICAL MEDICINE (2009)
The role of quantitative ultrasound in predicting osteoporosis defined by dual-energy X-ray absorptiometry in pre- and postmenopausal women
C. Dane et al.
CLIMACTERIC (2008)
Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia
Taishiro Kishimoto et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Risk of hip fracture in patients with a history of schizophrenia
Louise Howard et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Calcaneous quantitative ultrasound measurements predicts vertebral fractures in idiopathic male osteoporosis
Szilvia Meszaros et al.
JOINT BONE SPINE (2007)
Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls
B. M. Nilsson et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Osteoporosis in patients with schizophrenia
M Hummer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Body composition changes with age have gender-specific impacts on bone mineral density
S Lim et al.
BONE (2004)
Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management
PM Haddad et al.
DRUGS (2004)
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
AM Meaney et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Bone mineral density and prolactin associations in patients with chronic schizophrenia
G Abraham et al.
SCHIZOPHRENIA RESEARCH (2003)
A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip
ML Frost et al.
CALCIFIED TISSUE INTERNATIONAL (2002)
Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia
N Yasui-Furukori et al.
PSYCHOPHARMACOLOGY (2002)
Quantitative ultrasound of bone in male osteoporosis
D Mulleman et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Vitamin D insufficiency in Japanese female college students: a preliminary report
K Nakamura et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2001)
The role of quantitative ultrasound in predicting osteoporosis defined by dual X-ray absorptiometry
A Çetin et al.
RHEUMATOLOGY INTERNATIONAL (2001)
Clinical performance of a highly portable, scanning calcaneal ultrasonometer
SL Greenspan et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Share Paper
